A

Ascendis Pharma A/S
D

ASND

162.080
USD
2.29
(1.43%)
مغلق
حجم التداول
11,309
الربح لكل سهم
-5
العائد الربحي
-
P/E
-25
حجم السوق
9,798,886,282
أصول ذات صلة
ADBE
ADBE
-6.62
(-1.60%)
407.54 USD
CRM
CRM
-8.91
(-3.16%)
273.09 USD
GOOGL
GOOGL
-3.470
(-2.02%)
168.480 USD
IBM
IBM
-0.06
(-0.02%)
258.71 USD
INTU
INTU
53.88
(8.09%)
719.83 USD
MSFT
MSFT
-3.09
(-0.68%)
450.25 USD
NOW
NOW
-11.33
(-1.12%)
1,004.30 USD
TWLO
TWLO
-3.520
(-3.01%)
113.480 USD
المزيد
الأخبار المقالات

العنوان: Ascendis Pharma A/S

القطاع: Healthcare
الصناعة: Biotechnology
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.